Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Evolocumab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amgen owes Regeneron $407M after defeat in PCSK9 antitrust suit
    Amgen owes Regeneron $407M after defeat in PCSK9 antitrust suit

    17 May 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/amgen-hook-pay-more-400m-after-regeneron-triumphs-cholesterol-drug-antitrust-suit

    FIERCE PHARMA
    17 May 2025
    Share Share
    Amgen`s Biologic Repatha Receives Suppl Approval in US
    Amgen`s Biologic Repatha Receives Suppl Approval in US

    20 Nov 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125522

    FDA
    20 Nov 2024
    Share Share
    Amgen`s Biologic Repatha (Evolocumab) Receives Suppl Approvals in US
    Amgen`s Biologic Repatha (Evolocumab) Receives Suppl Approvals in US

    19 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125522

    FDA
    19 Aug 2024
    Share Share
    Amgen 1Q Results
    Amgen 1Q Results

    21 May 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-05-21/amgen-1q-results/?widget=listSection

    CONTRACT PHARMA
    21 May 2024
    Share Share
    U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents
    U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents

    28 Mar 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/amgen-bid-revive-cholesterol-drug-patents-comes-us-supreme-court-2023-03-27/

    REUTERS
    28 Mar 2023
    Share Share
    Amgen-Sanofi patent case divides makers of antibody drugs
    Amgen-Sanofi patent case divides makers of antibody drugs

    27 Mar 2023

    // REUTERS

    https://www.reuters.com/legal/amgen-sanofi-patent-case-divides-makers-antibody-drugs-2023-03-27/

    REUTERS
    27 Mar 2023
    Share Share